To investigate the direct role of
interleukin (IL) 6 in the development of
rheumatoid arthritis, IL-6-deficient (IL-6 -/-) mice were backcrossed for eight generations into C57BL/6 mice, a strain of mice with a genetic background of susceptibility for
antigen-induced
arthritis (AIA). Both histological and immunological comparisons were made between IL-6-deficient (IL-6 -/-) mice and wild-type (IL-6 +/+) littermates after the induction of AIA. Although all
IL-6 +/+ mice developed severe
arthritis, only mild
arthritis was observed in
IL-6 -/- mice.
Safranin O staining demonstrated that articular cartilage was well preserved in
IL-6 -/- mice, whereas it was destroyed completely in
IL-6 +/+ mice. In addition, comparable
mRNA expression for both IL-1beta and
tumor necrosis factor alpha, but not for
IL-6, was detected in the inflamed joints of
IL-6 -/- mice, suggesting that
IL-6 may play a more crucial role in cartilage destruction than either IL-1beta or
tumor necrosis factor alpha. In immunological comparisons, both
antigen-specific in vitro proliferative response in lymph node cells and in vivo antibody production were elicited in
IL-6 -/- mice, but they were reduced to less than half of that found in
IL-6 +/+ mice. Lymph node cells of
IL-6 -/- mice produced many more Th2
cytokines than did
IL-6 +/+ mice with either
antigen-specific or nonspecific stimulation in in vitro culture. Taken together, these results indicate that
IL-6 may play a key role in the development of AIA at the inductive as well as the effector phase, and the blockade of
IL-6 is possibly beneficial in the treatment of
rheumatoid arthritis.